Minjun Chen is a principal investigator working at the Division of Bioinformatics and Biostatics of the US FDA’s National Center for Toxicological Research and serve as the adjunct faculty and mentor for the bioinformatics program joint by Univ. of Arkansas at Little Rock (UALR) and Univ. of Arkansas for Medical Sciences (UAMS). Currently, he co-chairs the FDA Liver Toxicity Working Group since 2014 and is the editor of the Springer book titled “Drug-induced Liver Toxicity”. His primary research interests encompass drug-induced liver injury, drug safety, bioinformatics, and personalized medicine. He has authored or co-authored more than 80 scientific publications and book chapters.
Willem M. de Vos is Professor of Microbiology at Wageningen University & Finland Academy Professor at Helsinki University. He supervised over 90 PhD students & published over 500 peer-reviewed publications. His research aims to understand & exploit microbes using molecular, (meta)genomics & systems approaches. His current interest is focused on the human intestinal tract. He received various prizes, including the Rhone Poulenc Dairy Science Award, the NWO Spinoza Award & an ERC Advanced Grant.
Principal Investigator at the National Institute for Infectious Diseases L. Spallanzani IRCCS (Rome, Italy)
Professor of Proteomics at the Faculty of Sciences of the University of Rome Tor Vergata
Associate Professor Joan Heath received her undergraduate and PhD degrees in Cambridge, England, where she studied the role of osteoblast-osteoclast interactions and matrix metalloproteinase activity in the breakdown of bone. After post-doctoral positions in bone biology and osteoporosis research at the Merck Sharp and Dohme Research Laboratories in Philadelphia, USA and St. Vincent’s Institute for Medical Research in Melbourne, Australia, Joan joined the Melbourne-Parkville Branch of the Ludwig Institute for Cancer Research and switched her focus to colon cancer, becoming joint-head of the Colon Molecular and Cell Biology laboratory in 1998. Shortly after this time she adopted the zebrafish as a vertebrate model in which to discover genes with functions in intestinal development that may also be critical for the development and progression of colon cancer. In October 2012 she moved her laboratory to the Walter and Eliza Hall Institute of Medical Research in Melbourne, where she is a member of the Development and Cancer Division.
Coriobacteriia associated with the gut microbiota
Effect of gut-derived microbial metabolites on host health
Use of in vitro systems to study diet–microbiome interactions
Dr. Sushil Kumar is a Research Assistant professor at the Oregon Health & Science University (OHSU), Portland Oregon. He obtained his PhD from Max Planck Institute for biochemistry, Munich Germany where he worked in supervision of Prof. Axel Ullrich for studying cancer cell signaling. He did his postdoctoral work in Prof. Reto Schwendener’s laboratory at University of Zurich where he developed liposomal drugs for targeted delivery of payloads to macrophages as novel cancer therapy approach. He joined OHSU in 2012 in Prof. Lisa Coussens' laboratory where he has continued his research for studying cancer inflammation and developing immunotherapeutic approaches for cancer. He is employing ex vivo as well as mouse models for understanding immune cell phenotype for analyzing their role in cancer progression and developing novel therapeutics as well as biomarkers for cancer.
Yeong Yeh Lee, MD, PhD, FACP, FRCP, FACG. He is Professor of Medicine and Consultant of Gastroenterology, Hepatology & Internal Medicine with the School of Medical Sciences, Universiti Sains Malaysia. Dr. Lee is particularly interested in neurogastroenterology & functional gastrointestinal diseases. He is also the editor of BMC Gastroenterology, Journal of Royal College of Physicians of Edinburgh (JRCPE) and Malaysian Journal of Medical Sciences (MJMS).
Professor of Pharmacology and Toxicology, Zunyi Medical College, China. Editorial Board position on several journals such as Toxicological Sciences, Environmental Health Perspective. Recognized by Elsevier journals and EHP as "top reviewer" in 2012 in the field of Pharmacology and Toxicology
Veronika Lukacs-Kornek, is a Junior professor for molecular immunology and gastroenterology at the University of Saarland, Germany and the Sofja Kovalevskaja Award winner in 2012 (Alexander von Humboldt Foundation).
Research field includes dendritic cell biology, antigen presentation, immunoregulatory circuits operating in secondary lymphoid organs and the study of stromal cell-immune cell interactions.
Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan. President of The Physiological Society of Japan. Chief Editor, Journal of Physiological Sciences; Editor, Springer Plus; Editor of Frontiers in Physiology
Assistant professor of Human Nutrition, School of Medicine and Psychology, Department of Clinical and Molecular Medicine, "La Sapienza" University, Rome, Italy. PhD in Biology and Pathology of Ageing and member of the European Association for the Study of Diabetes (EASD). Research areas: Diabetes, Endocrinology and Metabolism.
Professor at the school of Pediatrics - Univ. Turin. Studying nutrition, metabolism of infancy in particular hormones such as Leptin, IGF-1, Ghrelin, Adiponectin. Takes interest in gastrointestinal and nutritional disorders. He studies in detail some aspects of gut microbiota of colicky infants such low level of lactobacilli and increased concentration of E.Coli. Performed relevant research on the effect of probiotics on colicky infants. Author of more than 100 scientific reports.